MustafaSahinMD

Child Neurology • Boston, MA

Neurologist-in-Chief and Chair of Neurology, Boston Children's Hospital; Professor of Neurology, Harvard Medical School

Join to view full profile

Dr. Sahin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sahin's full profile

Already have an account?

Office
300 Longwood Ave
# Fegan
Boston, MA 02115
Phone+1 617-355-6388

Fax+1 617-730-0284

Summary

Dr. Mustafa Sahin is a Child Neurologist in Boston, MA and is affiliated with Boston Children's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 22 years. He is experienced in tuberous sclerosis, autism spectrum disorders, and neurogenetics.

Education & Training

Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 1997 - 2000
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1995 - 1997
Yale School of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 2000 - 2025
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

Elected Member National Academy of Medicine, 2023
The 2018 Philip R. Dodge Lecture Washington University, St Louis MO, 2018
The Jacob’s Ladder Norman Saunders International Research Prize Hospital for Sick Children, Toronto, Canada, 2017
The 32nd Annual Colleen Giblin Memorial Lecture Columbia University Medical Center, New York, NY, 2017
The 28th Annual Rita G. Rudel/Lucy M. Moses Lecture Columbia University Medical Center, New York, NY, 2015
Young Investigator Award Child Neurology Society, 2005
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2011 Jan 01
Completed
Phase 2
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures Start of enrollment: 2013 Apr 29
Completed
Phase 3
Treatment of Rett Syndrome With Recombinant Human IGF-1 Start of enrollment: 2013 Jan 01
Completed
Phase 2
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) Start of enrollment: 2013 Jan 01
Completed
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome Start of enrollment: 2015 May 01
Recruiting
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations Start of enrollment: 2015 May 01
Recruiting
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC) Start of enrollment: 2015 May 01
Recruiting
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome Start of enrollment: 2016 Mar 01
Completed
Phase 2
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex Start of enrollment: 2016 Dec 01
Completed
Phase 2
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome Start of enrollment: 2017 Jun 12
Completed
Phase 1, Phase 2
Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis Start of enrollment: 2020 Sep 01
Completed
Not Applicable
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants Start of enrollment: 2020 Sep 08
Completed
Phase 1, Phase 2
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia Start of enrollment: 2020 Apr 27
Recruiting
Join now to see all

Publications & Presentations

PubMed

Discovering translational biomarkers in neurodevelopmental disorders.
Mustafa Sahin, Stephanie R Jones, John A Sweeney, Elizabeth Berry-Kravis, Barry W Connors
Nature reviews. Drug discovery. 2019-04-03
Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47).
Julian Teinert, Robert Behne, Angelica D'Amore, Miriam Wimmer, Sean Dwyer
Stem cell research. 2019-09-17

Press Mentions

Disrupted Cell Skeletons May Explain Brain Wiring Changes in Autism-Linked ConditionJune 28th, 2021
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals with PTEN Mutations: Study Design and Statistical ConsiderationsFebruary 6th, 2021
Earlier Treatment Could Help Reverse Autistic-like Behavior in Tuberous SclerosisOctober 10th, 2018
Join now to see all